Berkshire Hathaway's Teva- Pharmaceutical Industries Stake
Warren Buffett started to build up the position in Teva- Pharmaceutical Industries in Q4 2017 and continued to invest until Q2 2018. Since then they sold 43.2M shares. The investor completely sold their stake between Q1 2020 and Q4 2021.
Avg closing price
Price range
Sold -42.8M shares
Q4 2021
Avg closing price
$9.03
Price range
$7.90
-
$10.19
Sold 1.1% shares (-460k shares)
Q1 2020
Avg closing price
$10.24
Price range
$6.69
-
$13.45
Increased shares by 6.7% (+2.71M shares)
Q2 2018
Avg closing price
$20.39
Price range
$16.77
-
$24.71
Increased shares by 114.8% (+21.7M shares)
Q1 2018
Avg closing price
$19.52
Price range
$16.68
-
$22.07
New holding (+18.9M shares)
Q4 2017
Avg closing price
$15.04
Price range
$11.23
-
$19.10
